Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock von Bellomo, Rinaldo, Wunderink, Richard G, Szerlip, Harold, English, Shane W, Busse, Laurence W, Deane, Adam M, Khanna, Ashish K, McCurdy, Michael T, Ostermann, Marlies, Young, Paul J, Handisides, Damian R, Chawla, Lakhmir S, Tidmarsh, George F, Albertson, Timothy E

Volltext

Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock von Leisman, Daniel E., Handisides, Damian R., Chawla, Lakhmir S., Albertson, Timothy E., Busse, Laurence W., Boldt, David W., Deane, Adam M., Gong, Michelle N., Ham, Kealy R., Khanna, Ashish K., Ostermann, Marlies, McCurdy, Michael T., Thompson, B. Taylor, Tumlin, James S., Adams, Christopher D., Hodges, Tony N., Bellomo, Rinaldo

Volltext

ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock von Leisman, Daniel E, Handisides, Damian R, Busse, Laurence W, Chappell, Mark C, Chawla, Lakhmir S, Filbin, Michael R, Goldberg, Marcia B, Ham, Kealy R, Khanna, Ashish K, Ostermann, Marlies, McCurdy, Michael T, Adams, Christopher D, Hodges, Tony N, Bellomo, Rinaldo

Volltext

Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug von Hu, Jinsong, Handisides, Damian R., Van Valckenborgh, Els, De Raeve, Hendrik, Menu, Eline, Vande Broek, Isabelle, Liu, Qian, Sun, Jessica D., Van Camp, Ben, Hart, Charles P., Vanderkerken, Karin

Volltext

A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma von Laubach, Jacob P, Liu, Chia-Jen, Raje, Noopur S, Yee, Andrew J, Armand, Philippe, Schlossman, Robert L, Rosenblatt, Jacalyn, Hedlund, Jacquelyn, Martin, Michael, Reynolds, Craig, Shain, Kenneth H, Zackon, Ira, Stampleman, Laura, Henrick, Patrick, Rivotto, Bradley, Hornburg, Kalvis T V, Dumke, Henry J, Chuma, Stacey, Savell, Alexandra, Handisides, Damian R, Kroll, Stew, Anderson, Kenneth C, Richardson, Paul G, Ghobrial, Irene M

Volltext

Phase I study of evofosfamide, an investigational hypoxia‐activated prodrug, in patients with advanced leukemia von Badar, Talha, Handisides, Damian R., Benito, Juliana M., Richie, Mary Ann, Borthakur, Gautam, Jabbour, Elias, Harutyunyan, Karine, Konoplev, Sergej, Faderl, Stefan, Kroll, Stew, Andreeff, Michael, Pearce, Tillman, Kantarjian, Hagop M., Cortes, Jorge E., Thomas, Deborah A., Konopleva, Marina

Volltext

A Phase 1/2 Study of evofosfamide, A Hypoxia-Activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma von Laubach, Jacob P., Liu, Chia-Jen, Raje, Noopur S., Yee, Andrew J., Armand, Philippe, Schlossman, Robert L., Rosenblatt, Jacalyn, Hedlund, Jacquelyn, Martin, Michael, Reynolds, Craig, Shain, Kenneth H., Zackon, Ira, Stampleman, Laura, Henrick, Patrick, Rivotto, Bradley, Hornburg, Kalvis T.V., Dumke, Henry J., Chuma, Stacey, Savell, Alexandra, Handisides, Damian R., Kroll, Stew, Anderson, Kenneth C., Richardson, Paul G., Ghobrial, Irene M.

Volltext

Leukemia Microenvironment and Pathologic Hypoxia: Sensitivity to Hypoxia-Activated Cytotoxin TH-302 von Benito, Juliana M, Andrei, Volgin Y, Chen, Ye, Hongbo, Lu, Shi, Yuexi, McQueen, Teresa, Zweidler-McKay, Patrick A, Handisides, Damian R, Hart, Charles, Andreeff, Michael, Konopleva, Marina

Volltext

Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, and Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma von Ghobrial, Irene M., Laubach, Jacob P., Raje, Noopur, Armand, Philippe, Schlossman, Robert L., Boswell, Erica N, Hanlon, Courtney, Chuma, Stacey, Handisides, Damian R, Kroll, Stewart, Anderson, Kenneth C., Richardson, Paul G.

Volltext

A Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, In Patients With Advanced Leukemias von Konopleva, Marina, Handisides, Damian R, Richie, Mary Ann, Benito, Juliana M, Borthakur, Gautam, Jabbour, Elias J., Faderl, Stefan H., Cortes, Jorge E., Kroll, Stewart, Andreeff, Michael, Kantarjian, Hagop M, Thomas, Deborah A.

Volltext

Hypoxia Activated Prodrug TH-302 for the Treatment of Multiple Myeloma von Hu, Jinsong, Handisides, Damian R, Van Valckenborgh, Els, De Raeve, Hendrik, Menu, Eline, Broek, Isabelle Vande, Liu, Qian, Sun, Jessica D, Van Camp, Ben, Hart, Charles, Vanderkerken, Karin

Volltext

ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock von Leisman, Daniel E, Handisides, Damian R, Busse, Laurence W, Chappell, Mark C, Chawla, Lakhmir S, Filbin, Michael R, Goldberg, Marcia B, Ham, Kealy R, Khanna, Ashish K, Ostermann, Marlies, McCurdy, Michael T, Adams, Christopher D, Hodges, Tony N, Bellomo, Rinaldo

Volltext

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock von Bellomo, Rinaldo, Wunderink, Richard G, Szerlip, Harold, English, Shane W, Busse, Laurence W, Deane, Adam M, Khanna, Ashish K, McCurdy, Michael T, Ostermann, Marlies, Young, Paul J, Handisides, Damian R, Chawla, Lakhmir S, Tidmarsh, George F, Albertson, Timothy E

Volltext

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial von Bellomo, Rinaldo, Forni, Lui G, Busse, Laurence W, McCurdy, Michael T, Ham, Kealy R, Boldt, David W, Hästbacka, Johanna, Khanna, Ashish K, Albertson, Timothy E, Tumlin, James, Storey, Kristine, Handisides, Damian, Tidmarsh, George F, Chawla, Lakhmir S, Ostermann, Marlies

Volltext

Preliminary safety and efficacy of evofosfamide (TH-302), an investigational hypoxia-activated prodrug, combined with bortezomib and dexamethasone in patients with relapsed/refract... von Laubach, Jacob, Raje, Noopur S., Yee, Andrew Jenho, Armand, Philippe, Schlossman, Robert L., Rosenblatt, Jacalyn, Hedlund, Jacquelyn Ann, Martin, Michael Gary, Reynolds, Craig H., Shain, Kenneth H., Zackon, Ira, Stampleman, Laura, Boswell, Erica, Chuma, Stacey, Liguori, Rebecca, Handisides, Damian, Kroll, Stew, Anderson, Kenneth Carl, Richardson, Paul G., Ghobrial, Irene M.

Volltext